Efficacy of prednisone 1–4 mg/day in patients with rheumatoid arthritis: a randomised, double-blind, placebo controlled withdrawal clinical trial

OBJECTIVE: A randomised double-blind placebo controlled withdrawal clinical trial of prednisone versus placebo in patients with rheumatoid arthritis (RA), treated in usual clinical care with 1–4 mg/day prednisone, withdrawn to the same dose of 1 mg prednisone or identical placebo tablets. METHODS: A...

Descripción completa

Detalles Bibliográficos
Autores principales: Pincus, T, Swearingen, C J, Luta, G, Sokka, T
Formato: Texto
Lenguaje:English
Publicado: BMJ Group 2009
Materias:
Clinical and Epidemiological Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2756955/
https://www.ncbi.nlm.nih.gov/pubmed/19074913
http://dx.doi.org/10.1136/ard.2008.095539

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2756955/
https://www.ncbi.nlm.nih.gov/pubmed/19074913
http://dx.doi.org/10.1136/ard.2008.095539

Ejemplares similares